Novartis
NVS
NVS
1,353 hedge funds and large institutions have $15.9B invested in Novartis in 2025 Q2 according to their latest regulatory filings, with 116 funds opening new positions, 488 increasing their positions, 467 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,353
Holders Change
+15
Holders Change %
+1.12%
% of All Funds
18.14%
Holding in Top 10
16
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
116
Increased
488
Reduced
467
Closed
72
Calls
$269M
Puts
$331M
Net Calls
-$61.7M
Net Calls Change
-$26.9M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$60.9M |
| 2 |
Optiver Holding
Amsterdam,
Netherlands
|
+$57.3M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$56.8M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$55M |
| 5 |
Millennium Management
New York
|
+$50.5M |
Top Sellers
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$206M |
| 2 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
-$165M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$142M |
| 4 |
Goldman Sachs
New York
|
-$135M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119M |